Determining the cause of vulvovaginal symptoms

Obstetrical and Gynecological Survey

Volumn 63, Issue 7, 2008, Pages 445-464

  Farage, Miranda A ^a   Miller, Kenneth W ^a   Ledger, William J ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; AZITHROMYCIN; BENZOCAINE; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; CLOBETASOL PROPIONATE; CLOTRIMAZOLE; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; FAMCICLOVIR; FLUCONAZOLE; FLUOCINONIDE; FRAMYCETIN; KETOCONAZOLE; LANOLIN; MACROLIDE; METRONIDAZOLE; MICONAZOLE; NEOMYCIN; NITROIMIDAZOLE; OFLOXACIN; SODIUM METABISULFITE; SPECTINOMYCIN; TACROLIMUS; TETRACYCLINE; UNINDEXED DRUG; VALACICLOVIR;

CANDIDIASIS; CLINICAL FEATURE; CONTACT DERMATITIS; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; HERPES SIMPLEX; HUMAN; HYPERSENSITIVITY REACTION; LICHEN PLANUS; PRACTICE GUIDELINE; PSORIASIS; REVIEW; SEBORRHEIC DERMATITIS; SELF CARE; TRICHOMONIASIS; UTERINE CERVICITIS; VAGINITIS; VULVAR PSORIASIS; VULVOVAGINAL DISEASE; VULVOVAGINITIS; FEMALE; MICROBIOLOGY; VAGINA DISCHARGE; VULVA PRURITUS; VULVAR VESTIBULITIS;

DERMATITIS, CONTACT; FEMALE; HUMANS; LICHEN PLANUS; PRURITUS VULVAE; VAGINAL DISCHARGE; VAGINITIS; VULVAR VESTIBULITIS;

EID: 55449092936     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e318172ee25     Document Type: Review

References (90)

1. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991 ;165 (4 Pt 2):1168-1176.
2. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines 2006. Diseases Characterized by Vaginal Discharge. Bacterial Vaginosis, 2006. Available at: http://www.cdc.gov/std/treatment/2006/ vaginal-discharge.htm#vagdis2. Accessed September 4, 2007.
3. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353:1899-1911. (Pubitemid 41565955)
4. 4. Thorsen P, Jensen IP, Jeune B, et al. Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women. Am J Obstet Gynecol 1998;178: 580-587. (Pubitemid 28207514)
5. Zhou X, Bent SJ, Schneider MG, et al. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004;150 (Pt 8):2565-2573.
6. 6. Zhou X, Brown CJ, Abdo Z, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007;1:121-133. (Pubitemid 46878155)
7. 7. Klebanoff MA, Schwebke JR, Zhang J, et al. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol 2004;104:267-272. (Pubitemid 40458871)
8. 8. Royce RA, Jackson TP, Thorp JM Jr, et al. Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis 1999;26:96-102. (Pubitemid 29085309)
9. Cottrell BH. Vaginal douching. J Obstet Gynecol Neonatal Nurs 2003;32:12-18.
10. Ness RB, Hillier SL, Kip KE, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004;104: 761-769.
11. Ness RB, Hillier SL, Kip KE, et al. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. Am J Epidemiol 2005;161:186-195.
12. Rothman KJ, Funch DP, Alfredson T, et al. Randomized field trial of vaginal douching, pelvic inflammatory disease and pregnancy. Epidemiology 2003;14:340-348.
13. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
14. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991 ;29: 297-301.
15. Schwebke JR, Hillier SL, Sobel JD, et al. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 1996;88(4 Pt 1):573-576.
16. 16. Myziuk L, Romanowski B, Johnson SC. BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol 2003;41: 1925-1928. (Pubitemid 36576514)
17. 17. Geisler WM, Yu S, Venglarik M, et al. Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections. Sex Transm Infect 2004;80:401-405. (Pubitemid 39389561)
18. Yudin MH, Hillier SL, Wiesenfeld HC, et al. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003; 188: 318-323.
19. Langsford MJ, Dobbs FF, Morrison GM, et al. The effect of introduction of a guideline on the management of vaginal discharge and in particular bacterial vaginosis in primary care. Fam Pract 2001;18:253-257.
20. Welsh B, Howard A, Cook K. Vulval itch. Aust Fam Physician 2004;33:505-510.
21. Sobel JD. Vulvovaginitis due to Candida glabrata. An emerging problem. Mycoses 1998;41(suppl 2):18-22.
22. al-Rawi N, Kavanagh K. Characterisation of yeasts implicated in vulvovaginal candidosls in Irish women. Br J Biomed Sci 1999;56:99-104.
23. Corsello S, Spinillo A, Osnengo G, et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol 2003;110:66-72. (Pubitemid 37025702)
24. Arzeni D, Del Poeta M, Simonettl O, et al. Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy. Eur J Epidemiol 1997;13:447-450. (Pubitemid 27306193)
25. Mardh PA, Rodrigues AG, Genc M, et al. Facts and myths on recurrent vulvovaginal candidosis-a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS 2002;13:522-539. (Pubitemid 34816236)
26. 26. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-211. (Pubitemid 28124116)
27. Nyirjesy P, Sobel JD. Vulvovaginal candidiasis. Obstet Gynecol Clin North Am 2003;30:671-684.
28. 28. Babula O, Lazdane G, Kroica J, et al. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 2003; 37:733-737. (Pubitemid 37100818)
29. Spinillo A, Capuzzo E, Acciano S, et al. Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis. Am J Obstet Gynecol 1999;180(1 Pt 1):14-17. (Pubitemid 29088381)
30. Xu J, Sobel JD. Antibiotic-associated vulvovaginal candidiasis. Curr Infect Dis Rep 2003;5:481-487.
31. Handa VL, Stice CW. Fungal culture findings in cyclic vulvitis. Obstet Gynecol 2000;96:301-303.
32. Eckert LO, Hawes SE, Stevens CE, et al. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol 1998;92:757-765.
33. 33.FerrisDG,DekleC,LitakerMS.Women'suseofover- thecounterantifungalmedicationsforgynecologicsymptoms.JFamPract1996;42:595-600. (Pubitemid26188705)
34. 34. Weissenbacher S, Witkin SS, Tolbert V, et al. Value of Candida polymerase chain reaction and vaginal cytokine analysis for the differential diagnosis of women with recurrent vulvovaginitis. Infect Dis Obstet Gynecol 2000;8:244-247. (Pubitemid 32114474)
35. Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist's perspective. Australas J Dermatol 1996;37:12-18.
36. Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99:419-425. (Pubitemid 34188402)
37. Giraldo P, von Nowaskonski A, Gomes FA, et al. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Obstet Gynecol 2000;95:413-416. (Pubitemid 30100509)
38. Brown D Jr. Clinical variability of bacterial vaginosis and trichomoniasis. J Reprod Med 2004;49:781-786.
39. French JI, McGregor JA, Parker R. Readily treatable reproductive tract infections and preterm birth among black women. Am J Obstet Gynecol 2006;194:1717-1726; discussion 26-27.
40. Newton ER, Piper JM, Shain RN, et al. Predictors of the vaginal microflora. Am J Obstet Gynecol 2001;184:845-853; discussion 53-55.
41. Schwebke JR. Update of trichomoniasis. Sex Transm Infect 2002;78:378-379.
42. Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001 ;7: 927-932.
43. Huppert JS, Batteiger BE, Braslins P, et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol 2005;43: 684-687.
44. 44.GaydosCA,QuinnTC. Urinenucleicacidamplificationtestsforthediagnosisofsexuallytransmittedinfection sinclinicalpractice.CurrOpinInfectDis2005;18:55-66.(Pubitemid41716241)
45. Radonjic IV, Dzamic AM, Mitrovic SM, et al. Diagnosis of Trichomonas vaginalis infection: the sensitivities and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol Reprod Biol 2006;126:116-120.
46. Caliendo AM, Jordan JA, Green AM, et al. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect Dis Obstet Gynecol 2005;13:145-150.
47. Wendel KA, Erbelding EJ, Gaydos CA, et al. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002;35: 576-580.
48. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines 2006. Diseases Characterized by Vaginal Discharge. Trichomoniasis, 2006. Available at: http://www.cdc.gov/std/treatment/2006/ vaginal-discharge.htm#vagdis3. Accessed September 4, 2007.
49. 49. Cudmore SL, Delgaty KL, Hayward-McClelland SF, et al. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev 2004;17: 783-793. (Pubitemid 39372517)
50. 50. Khan A, Fortenberry JD, Juliar BE, et al. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment. Sex Transm Dis 2005;32:260-264. (Pubitemid 40411586)
51. Lichtenstein B, Schwebke JR. Partner notification methods for African American men being treated for trichomoniasis: a consideration of main men, Second Hitters, and Third Players. Med Anthropol Q 2005;19:383-401.
52. Curran JW, Rendtorff RC, Chandler RW, et al. Female gonorrhea: its relation to abnormal uterine bleeding, uurinary tract symptoms, and cervicitis. Obstet Gynecol 1975;45: 195-198.
53. Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol 1994;171:12151220.
54. Ramer MA, Altchek A, Deligdisch L, et al. Lichen planus and the vulvovaginal-gingival syndrome. J Periodontal 2003;74: 1385-1393.
55. Petruzzi M, De Benedittis M, Carriero C, et al. Oro-vaginalvulvar lichen planus: report of two new cases. Maturitas 2005; 50:140-150. (Pubitemid 40094762)
56. Ridley CM. Chronic erosive vulval disease. Clin Exp Dermatol 1990;15:245-252.
57. Elsen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:431-436.
58. Farage MA. Vulvar susceptibility to contact irritants and allergens: a review. Arch Gynecol Obstet 2005;272:167-172.
59. Crone AM, Stewart EJ, Wojnarowska F, et al. Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venereol 2000;14:181-186.
60. Marren P, Wojnarowska F, Powell S. Allergic contact dermatitis and vulvar dermatoses. Br J Dermatol 1992; 126: 52-56.
61. Borgatta L Sensitivity to deodorant sanitary pads. JAMA 1978;240:1239-1240.
62. 62.EasonEL,FeldmanP. ContactdermatitisassociatedwiththeuseofAlwayssanitarynapkins.CMAJ1996;154: 1173-1176.(Pubitemid26143693)
63. Fisher AA. Allergic reaction to feminine hygiene sprays. Arch Dermatol 1973;108:801-802.
64. Poskitt BL, Wojnarowska FT, Shaw S. Seminen contact urticaria. J R Soc Med 1995;88:108P-109P.
65. 65. Lewis FM, Shah M, Gawkrodger DJ. Contact sensitivity in pruritus vulvae: patch test results and clinical outcome. Am J Contact Dermat 1997;8:137-140. (Pubitemid 27376819)
66. Britz MB, Maibach HI. Human labia majora skin: transepidermal water loss in vivo. Acta Derm Venereol Suppl (Stockh) 1979;59:23-25.
67. 67.EisnerP,WilhelmD,MaibachHI. Physiologicalskinsurfacewaterlossdynamicsofhumanvulvarandforearmskin. ActaDermVenereol1990;70:141-144.(Pubitemid20068316)
68. Yesudian PD, Sugunendran H, Bates CM, et al. Lichen sclerosus. Int J STD AIDS 2005;16:465-473; test 74.
69. 69. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006;296:964-973. (Pubitemid 44285373)
70. Haefner HK, Collins ME, Davis GD, et al. The vulvodynia guideline. J Low Genit Tract Dis 2005;9:40-51.
71. Farage MA, Galask RP. Vulvar vestibulitis syndrome: a review. Eur J Obstet Gynecol Reprod Biol 2005;123:9-16.
72. Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med 1987;32:110-114.
73. 73. Bergeron S, Binik YM, Khalife S, et al. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001;98:45-51. (Pubitemid 32622762)
74. 74. Lowenstein L, Vardi Y, Deutsch M, et al. Vulvar vestibulitis severity-assessment by sensory and pain testing modalities. Pain 2004;107:47-53. (Pubitemid 38058698)
75. 75. Pukali CF, Binik YM, Khalife S. A new instrument for pain assessment in vulvar vestibulitis syndrome. J Sex Marital Ther 2004;30:69-78. (Pubitemid 38228856)
76. Bohm-Starke N, Hilliges M, Blomgren B, et al. increased blood flow and erythema in the posterior vestibular mucosa in vulvar vestibulltis(1). Obstet Gynecol 2001;98:10671074.
77. Bohm-Starke N, Hilliges M, Brodda-Jansen G, et al. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain 2001;94:177-183.
78. Bohm-Starke N, Hilliges M, Falconer C, et al. increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1998;46:256-260.
79. Bohm-Starke N, Hilliges M, Falconer C, et al. Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1999;48: 270-275.
80. 80. Tympanidis P, Terenghi G, Dowd P. increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 2003;148:1021-1027. (Pubitemid 36750798)
81. Gerber S, Bongiovanni AM, Ledger WJ, et al. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002; 186:696-700.
82. Foster DC, Sazenski TM, Stodgell CJ. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med 2004;49:503-509.
83. 83. Babula O, Danielsson I, Sjoberg I, et al. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2004; 191:762-766. (Pubitemid 39298106)
84. 84. Babula O, Bongiovanni AM, Ledger WJ, et al. immunoglobulin E antibodies to seminal fluid in women with vulvar vestibulitis syndrome: relation to onset and timing of symptoms. Am J Obstet Gynecol 2004;190:663-667. (Pubitemid 38406775)
85. Ramirez De Knott HM, McCormick TS, Do SO, et al. Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia. Contact Dermatitis 2005;53:214-218.
86. 86. Wiesenfeld HC, Macio I. The infrequent use of office-based diagnostic tests for vaginitis. Am J Obstet Gynecol 1999;181 : 39-41. (Pubitemid 29343328)
87. 87. Ledger WJ, Monif GR. A growing concern: inability to diagnose vulvovaginal infections correctly. Obstet Gynecol 2004; 103:782-784. (Pubitemid 40459043)
88. 88. Allen-Davis JT, Beck A, Parker R, et al. Assessment of vulvovaginal complaints: accuracy of telephone triage and in-office diagnosis. Obstet Gynecol 2002;99:18-22. (Pubitemid 34075462)
89. Schwiertz A, Taras D, Rusch K, et al. Throwing the dice for the diagnosis of vaginal complaints? Ann Clin Microbiol Antimicrob 2006;5:4.
90. 90. Ledger WJ, Kessler A, Leonard GH, et al. Vulvar vestibulitis: a complex clinical entity. Infect Dis Obstet Gynecol 1996;4: 269-275. (Pubitemid 27290804)